0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Internal Neuromodulation Device Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-9G1071
Home | Market Reports | Health| Health Conditions
Global Internal Neuromodulation Device Market Research Report 2020
BUY CHAPTERS

Global Internal Neuromodulation Device Market Research Report 2025

Code: QYRE-Auto-9G1071
Report
May 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Internal Neuromodulation Device Market

The global market for Internal Neuromodulation Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Internal Neuromodulation Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Internal Neuromodulation Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Internal Neuromodulation Device include Medtronic PLC, BostonScientific Corporation, Cyberonics, BioControl Medical, Aleva Neurotherapeutics SA, Bioness, Uroplasty, Abbott Laboratories, St.Jude Medical, EnteroMedics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Internal Neuromodulation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Internal Neuromodulation Device.
The Internal Neuromodulation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Internal Neuromodulation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Internal Neuromodulation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Internal Neuromodulation Device Market Report

Report Metric Details
Report Name Internal Neuromodulation Device Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic PLC, BostonScientific Corporation, Cyberonics, BioControl Medical, Aleva Neurotherapeutics SA, Bioness, Uroplasty, Abbott Laboratories, St.Jude Medical, EnteroMedics, ,Micron Medical Corporation, LivaNova PLC, NeuroPace, Synapse Biomedical, Soterix Medical, Accellent, Neuros Medical, Nevro Corp
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Internal Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Internal Neuromodulation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Internal Neuromodulation Device Market report?

Ans: The main players in the Internal Neuromodulation Device Market are Medtronic PLC, BostonScientific Corporation, Cyberonics, BioControl Medical, Aleva Neurotherapeutics SA, Bioness, Uroplasty, Abbott Laboratories, St.Jude Medical, EnteroMedics, ,Micron Medical Corporation, LivaNova PLC, NeuroPace, Synapse Biomedical, Soterix Medical, Accellent, Neuros Medical, Nevro Corp

What are the Application segmentation covered in the Internal Neuromodulation Device Market report?

Ans: The Applications covered in the Internal Neuromodulation Device Market report are Hospital, Clinic, Home Healthcare, Other

What are the Type segmentation covered in the Internal Neuromodulation Device Market report?

Ans: The Types covered in the Internal Neuromodulation Device Market report are Metal Biomaterials, Polymer Biomaterial, Ceramic Biomaterial

Recommended Reports

Neuromodulation Devices

Neuro Intervention

Neurological Diagnostics

1 Internal Neuromodulation Device Market Overview
1.1 Product Definition
1.2 Internal Neuromodulation Device by Type
1.2.1 Global Internal Neuromodulation Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Metal Biomaterials
1.2.3 Polymer Biomaterial
1.2.4 Ceramic Biomaterial
1.3 Internal Neuromodulation Device by Application
1.3.1 Global Internal Neuromodulation Device Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Healthcare
1.3.5 Other
1.4 Global Internal Neuromodulation Device Market Size Estimates and Forecasts
1.4.1 Global Internal Neuromodulation Device Revenue 2020-2031
1.4.2 Global Internal Neuromodulation Device Sales 2020-2031
1.4.3 Global Internal Neuromodulation Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Internal Neuromodulation Device Market Competition by Manufacturers
2.1 Global Internal Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Internal Neuromodulation Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Internal Neuromodulation Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Internal Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Internal Neuromodulation Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Internal Neuromodulation Device, Product Type & Application
2.7 Global Key Manufacturers of Internal Neuromodulation Device, Date of Enter into This Industry
2.8 Global Internal Neuromodulation Device Market Competitive Situation and Trends
2.8.1 Global Internal Neuromodulation Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Internal Neuromodulation Device Players Market Share by Revenue
2.8.3 Global Internal Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Internal Neuromodulation Device Market Scenario by Region
3.1 Global Internal Neuromodulation Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Internal Neuromodulation Device Sales by Region: 2020-2031
3.2.1 Global Internal Neuromodulation Device Sales by Region: 2020-2025
3.2.2 Global Internal Neuromodulation Device Sales by Region: 2026-2031
3.3 Global Internal Neuromodulation Device Revenue by Region: 2020-2031
3.3.1 Global Internal Neuromodulation Device Revenue by Region: 2020-2025
3.3.2 Global Internal Neuromodulation Device Revenue by Region: 2026-2031
3.4 North America Internal Neuromodulation Device Market Facts & Figures by Country
3.4.1 North America Internal Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Internal Neuromodulation Device Sales by Country (2020-2031)
3.4.3 North America Internal Neuromodulation Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Internal Neuromodulation Device Market Facts & Figures by Country
3.5.1 Europe Internal Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Internal Neuromodulation Device Sales by Country (2020-2031)
3.5.3 Europe Internal Neuromodulation Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Internal Neuromodulation Device Market Facts & Figures by Region
3.6.1 Asia Pacific Internal Neuromodulation Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Internal Neuromodulation Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Internal Neuromodulation Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Internal Neuromodulation Device Market Facts & Figures by Country
3.7.1 Latin America Internal Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Internal Neuromodulation Device Sales by Country (2020-2031)
3.7.3 Latin America Internal Neuromodulation Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Internal Neuromodulation Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Internal Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Internal Neuromodulation Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Internal Neuromodulation Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Internal Neuromodulation Device Sales by Type (2020-2031)
4.1.1 Global Internal Neuromodulation Device Sales by Type (2020-2025)
4.1.2 Global Internal Neuromodulation Device Sales by Type (2026-2031)
4.1.3 Global Internal Neuromodulation Device Sales Market Share by Type (2020-2031)
4.2 Global Internal Neuromodulation Device Revenue by Type (2020-2031)
4.2.1 Global Internal Neuromodulation Device Revenue by Type (2020-2025)
4.2.2 Global Internal Neuromodulation Device Revenue by Type (2026-2031)
4.2.3 Global Internal Neuromodulation Device Revenue Market Share by Type (2020-2031)
4.3 Global Internal Neuromodulation Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Internal Neuromodulation Device Sales by Application (2020-2031)
5.1.1 Global Internal Neuromodulation Device Sales by Application (2020-2025)
5.1.2 Global Internal Neuromodulation Device Sales by Application (2026-2031)
5.1.3 Global Internal Neuromodulation Device Sales Market Share by Application (2020-2031)
5.2 Global Internal Neuromodulation Device Revenue by Application (2020-2031)
5.2.1 Global Internal Neuromodulation Device Revenue by Application (2020-2025)
5.2.2 Global Internal Neuromodulation Device Revenue by Application (2026-2031)
5.2.3 Global Internal Neuromodulation Device Revenue Market Share by Application (2020-2031)
5.3 Global Internal Neuromodulation Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic PLC
6.1.1 Medtronic PLC Company Information
6.1.2 Medtronic PLC Description and Business Overview
6.1.3 Medtronic PLC Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic PLC Internal Neuromodulation Device Product Portfolio
6.1.5 Medtronic PLC Recent Developments/Updates
6.2 BostonScientific Corporation
6.2.1 BostonScientific Corporation Company Information
6.2.2 BostonScientific Corporation Description and Business Overview
6.2.3 BostonScientific Corporation Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BostonScientific Corporation Internal Neuromodulation Device Product Portfolio
6.2.5 BostonScientific Corporation Recent Developments/Updates
6.3 Cyberonics
6.3.1 Cyberonics Company Information
6.3.2 Cyberonics Description and Business Overview
6.3.3 Cyberonics Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cyberonics Internal Neuromodulation Device Product Portfolio
6.3.5 Cyberonics Recent Developments/Updates
6.4 BioControl Medical
6.4.1 BioControl Medical Company Information
6.4.2 BioControl Medical Description and Business Overview
6.4.3 BioControl Medical Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BioControl Medical Internal Neuromodulation Device Product Portfolio
6.4.5 BioControl Medical Recent Developments/Updates
6.5 Aleva Neurotherapeutics SA
6.5.1 Aleva Neurotherapeutics SA Company Information
6.5.2 Aleva Neurotherapeutics SA Description and Business Overview
6.5.3 Aleva Neurotherapeutics SA Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Aleva Neurotherapeutics SA Internal Neuromodulation Device Product Portfolio
6.5.5 Aleva Neurotherapeutics SA Recent Developments/Updates
6.6 Bioness
6.6.1 Bioness Company Information
6.6.2 Bioness Description and Business Overview
6.6.3 Bioness Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bioness Internal Neuromodulation Device Product Portfolio
6.6.5 Bioness Recent Developments/Updates
6.7 Uroplasty
6.7.1 Uroplasty Company Information
6.7.2 Uroplasty Description and Business Overview
6.7.3 Uroplasty Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Uroplasty Internal Neuromodulation Device Product Portfolio
6.7.5 Uroplasty Recent Developments/Updates
6.8 Abbott Laboratories
6.8.1 Abbott Laboratories Company Information
6.8.2 Abbott Laboratories Description and Business Overview
6.8.3 Abbott Laboratories Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Abbott Laboratories Internal Neuromodulation Device Product Portfolio
6.8.5 Abbott Laboratories Recent Developments/Updates
6.9 St.Jude Medical
6.9.1 St.Jude Medical Company Information
6.9.2 St.Jude Medical Description and Business Overview
6.9.3 St.Jude Medical Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 St.Jude Medical Internal Neuromodulation Device Product Portfolio
6.9.5 St.Jude Medical Recent Developments/Updates
6.10 EnteroMedics
6.10.1 EnteroMedics Company Information
6.10.2 EnteroMedics Description and Business Overview
6.10.3 EnteroMedics Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 EnteroMedics Internal Neuromodulation Device Product Portfolio
6.10.5 EnteroMedics Recent Developments/Updates
6.11 ,Micron Medical Corporation
6.11.1 ,Micron Medical Corporation Company Information
6.11.2 ,Micron Medical Corporation Description and Business Overview
6.11.3 ,Micron Medical Corporation Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 ,Micron Medical Corporation Internal Neuromodulation Device Product Portfolio
6.11.5 ,Micron Medical Corporation Recent Developments/Updates
6.12 LivaNova PLC
6.12.1 LivaNova PLC Company Information
6.12.2 LivaNova PLC Description and Business Overview
6.12.3 LivaNova PLC Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 LivaNova PLC Internal Neuromodulation Device Product Portfolio
6.12.5 LivaNova PLC Recent Developments/Updates
6.13 NeuroPace
6.13.1 NeuroPace Company Information
6.13.2 NeuroPace Description and Business Overview
6.13.3 NeuroPace Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 NeuroPace Internal Neuromodulation Device Product Portfolio
6.13.5 NeuroPace Recent Developments/Updates
6.14 Synapse Biomedical
6.14.1 Synapse Biomedical Company Information
6.14.2 Synapse Biomedical Description and Business Overview
6.14.3 Synapse Biomedical Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Synapse Biomedical Internal Neuromodulation Device Product Portfolio
6.14.5 Synapse Biomedical Recent Developments/Updates
6.15 Soterix Medical
6.15.1 Soterix Medical Company Information
6.15.2 Soterix Medical Description and Business Overview
6.15.3 Soterix Medical Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Soterix Medical Internal Neuromodulation Device Product Portfolio
6.15.5 Soterix Medical Recent Developments/Updates
6.16 Accellent
6.16.1 Accellent Company Information
6.16.2 Accellent Description and Business Overview
6.16.3 Accellent Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Accellent Internal Neuromodulation Device Product Portfolio
6.16.5 Accellent Recent Developments/Updates
6.17 Neuros Medical
6.17.1 Neuros Medical Company Information
6.17.2 Neuros Medical Description and Business Overview
6.17.3 Neuros Medical Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Neuros Medical Internal Neuromodulation Device Product Portfolio
6.17.5 Neuros Medical Recent Developments/Updates
6.18 Nevro Corp
6.18.1 Nevro Corp Company Information
6.18.2 Nevro Corp Description and Business Overview
6.18.3 Nevro Corp Internal Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Nevro Corp Internal Neuromodulation Device Product Portfolio
6.18.5 Nevro Corp Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Internal Neuromodulation Device Industry Chain Analysis
7.2 Internal Neuromodulation Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Internal Neuromodulation Device Production Mode & Process Analysis
7.4 Internal Neuromodulation Device Sales and Marketing
7.4.1 Internal Neuromodulation Device Sales Channels
7.4.2 Internal Neuromodulation Device Distributors
7.5 Internal Neuromodulation Device Customer Analysis
8 Internal Neuromodulation Device Market Dynamics
8.1 Internal Neuromodulation Device Industry Trends
8.2 Internal Neuromodulation Device Market Drivers
8.3 Internal Neuromodulation Device Market Challenges
8.4 Internal Neuromodulation Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Internal Neuromodulation Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Internal Neuromodulation Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Internal Neuromodulation Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Internal Neuromodulation Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Internal Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Internal Neuromodulation Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Internal Neuromodulation Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Internal Neuromodulation Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Internal Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Internal Neuromodulation Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Internal Neuromodulation Device, Product Type & Application
 Table 12. Global Key Manufacturers of Internal Neuromodulation Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Internal Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Internal Neuromodulation Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Internal Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Internal Neuromodulation Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Internal Neuromodulation Device Sales Market Share by Region (2020-2025)
 Table 19. Global Internal Neuromodulation Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Internal Neuromodulation Device Sales Market Share by Region (2026-2031)
 Table 21. Global Internal Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Internal Neuromodulation Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Internal Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Internal Neuromodulation Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Internal Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Internal Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Internal Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Internal Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Internal Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Internal Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Internal Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Internal Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Internal Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Internal Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Internal Neuromodulation Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Internal Neuromodulation Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Internal Neuromodulation Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Internal Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Internal Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Internal Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Internal Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Internal Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Internal Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Internal Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Internal Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Internal Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Internal Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Internal Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Internal Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Internal Neuromodulation Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Internal Neuromodulation Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Internal Neuromodulation Device Sales Market Share by Type (2020-2025)
 Table 53. Global Internal Neuromodulation Device Sales Market Share by Type (2026-2031)
 Table 54. Global Internal Neuromodulation Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Internal Neuromodulation Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Internal Neuromodulation Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Internal Neuromodulation Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Internal Neuromodulation Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Internal Neuromodulation Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Internal Neuromodulation Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Internal Neuromodulation Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Internal Neuromodulation Device Sales Market Share by Application (2020-2025)
 Table 63. Global Internal Neuromodulation Device Sales Market Share by Application (2026-2031)
 Table 64. Global Internal Neuromodulation Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Internal Neuromodulation Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Internal Neuromodulation Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Internal Neuromodulation Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Internal Neuromodulation Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Internal Neuromodulation Device Price (US$/Unit) by Application (2026-2031)
 Table 70. Medtronic PLC Company Information
 Table 71. Medtronic PLC Description and Business Overview
 Table 72. Medtronic PLC Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Medtronic PLC Internal Neuromodulation Device Product
 Table 74. Medtronic PLC Recent Developments/Updates
 Table 75. BostonScientific Corporation Company Information
 Table 76. BostonScientific Corporation Description and Business Overview
 Table 77. BostonScientific Corporation Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BostonScientific Corporation Internal Neuromodulation Device Product
 Table 79. BostonScientific Corporation Recent Developments/Updates
 Table 80. Cyberonics Company Information
 Table 81. Cyberonics Description and Business Overview
 Table 82. Cyberonics Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Cyberonics Internal Neuromodulation Device Product
 Table 84. Cyberonics Recent Developments/Updates
 Table 85. BioControl Medical Company Information
 Table 86. BioControl Medical Description and Business Overview
 Table 87. BioControl Medical Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. BioControl Medical Internal Neuromodulation Device Product
 Table 89. BioControl Medical Recent Developments/Updates
 Table 90. Aleva Neurotherapeutics SA Company Information
 Table 91. Aleva Neurotherapeutics SA Description and Business Overview
 Table 92. Aleva Neurotherapeutics SA Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Aleva Neurotherapeutics SA Internal Neuromodulation Device Product
 Table 94. Aleva Neurotherapeutics SA Recent Developments/Updates
 Table 95. Bioness Company Information
 Table 96. Bioness Description and Business Overview
 Table 97. Bioness Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bioness Internal Neuromodulation Device Product
 Table 99. Bioness Recent Developments/Updates
 Table 100. Uroplasty Company Information
 Table 101. Uroplasty Description and Business Overview
 Table 102. Uroplasty Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Uroplasty Internal Neuromodulation Device Product
 Table 104. Uroplasty Recent Developments/Updates
 Table 105. Abbott Laboratories Company Information
 Table 106. Abbott Laboratories Description and Business Overview
 Table 107. Abbott Laboratories Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Abbott Laboratories Internal Neuromodulation Device Product
 Table 109. Abbott Laboratories Recent Developments/Updates
 Table 110. St.Jude Medical Company Information
 Table 111. St.Jude Medical Description and Business Overview
 Table 112. St.Jude Medical Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. St.Jude Medical Internal Neuromodulation Device Product
 Table 114. St.Jude Medical Recent Developments/Updates
 Table 115. EnteroMedics Company Information
 Table 116. EnteroMedics Description and Business Overview
 Table 117. EnteroMedics Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. EnteroMedics Internal Neuromodulation Device Product
 Table 119. EnteroMedics Recent Developments/Updates
 Table 120. ,Micron Medical Corporation Company Information
 Table 121. ,Micron Medical Corporation Description and Business Overview
 Table 122. ,Micron Medical Corporation Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. ,Micron Medical Corporation Internal Neuromodulation Device Product
 Table 124. ,Micron Medical Corporation Recent Developments/Updates
 Table 125. LivaNova PLC Company Information
 Table 126. LivaNova PLC Description and Business Overview
 Table 127. LivaNova PLC Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. LivaNova PLC Internal Neuromodulation Device Product
 Table 129. LivaNova PLC Recent Developments/Updates
 Table 130. NeuroPace Company Information
 Table 131. NeuroPace Description and Business Overview
 Table 132. NeuroPace Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. NeuroPace Internal Neuromodulation Device Product
 Table 134. NeuroPace Recent Developments/Updates
 Table 135. Synapse Biomedical Company Information
 Table 136. Synapse Biomedical Description and Business Overview
 Table 137. Synapse Biomedical Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Synapse Biomedical Internal Neuromodulation Device Product
 Table 139. Synapse Biomedical Recent Developments/Updates
 Table 140. Soterix Medical Company Information
 Table 141. Soterix Medical Description and Business Overview
 Table 142. Soterix Medical Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Soterix Medical Internal Neuromodulation Device Product
 Table 144. Soterix Medical Recent Developments/Updates
 Table 145. Accellent Company Information
 Table 146. Accellent Description and Business Overview
 Table 147. Accellent Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Accellent Internal Neuromodulation Device Product
 Table 149. Accellent Recent Developments/Updates
 Table 150. Neuros Medical Company Information
 Table 151. Neuros Medical Description and Business Overview
 Table 152. Neuros Medical Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Neuros Medical Internal Neuromodulation Device Product
 Table 154. Neuros Medical Recent Developments/Updates
 Table 155. Nevro Corp Company Information
 Table 156. Nevro Corp Description and Business Overview
 Table 157. Nevro Corp Internal Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Nevro Corp Internal Neuromodulation Device Product
 Table 159. Nevro Corp Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Internal Neuromodulation Device Distributors List
 Table 163. Internal Neuromodulation Device Customers List
 Table 164. Internal Neuromodulation Device Market Trends
 Table 165. Internal Neuromodulation Device Market Drivers
 Table 166. Internal Neuromodulation Device Market Challenges
 Table 167. Internal Neuromodulation Device Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Internal Neuromodulation Device
 Figure 2. Global Internal Neuromodulation Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Internal Neuromodulation Device Market Share by Type: 2024 & 2031
 Figure 4. Metal Biomaterials Product Picture
 Figure 5. Polymer Biomaterial Product Picture
 Figure 6. Ceramic Biomaterial Product Picture
 Figure 7. Global Internal Neuromodulation Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Internal Neuromodulation Device Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Home Healthcare
 Figure 12. Other
 Figure 13. Global Internal Neuromodulation Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Internal Neuromodulation Device Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Internal Neuromodulation Device Sales (2020-2031) & (K Units)
 Figure 16. Global Internal Neuromodulation Device Average Price (US$/Unit) & (2020-2031)
 Figure 17. Internal Neuromodulation Device Report Years Considered
 Figure 18. Internal Neuromodulation Device Sales Share by Manufacturers in 2024
 Figure 19. Global Internal Neuromodulation Device Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Internal Neuromodulation Device Players: Market Share by Revenue in Internal Neuromodulation Device in 2024
 Figure 21. Internal Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Internal Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Internal Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 24. North America Internal Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 25. United States Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Internal Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 28. Europe Internal Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Internal Neuromodulation Device Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Internal Neuromodulation Device Revenue Market Share by Region (2020-2031)
 Figure 36. China Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Internal Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Internal Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Internal Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Internal Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Internal Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Internal Neuromodulation Device by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Internal Neuromodulation Device by Type (2020-2031)
 Figure 55. Global Internal Neuromodulation Device Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Internal Neuromodulation Device by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Internal Neuromodulation Device by Application (2020-2031)
 Figure 58. Global Internal Neuromodulation Device Price (US$/Unit) by Application (2020-2031)
 Figure 59. Internal Neuromodulation Device Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart